List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #33,171 to #33,220.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. M. smegmatisMycobacterium smegmatis
  2. M. tuberculosisMycobacterium tuberculosis
  3. M. ulceransMycobacterium ulcerans
  4. M. xenopiMycobacterium xenopi
  5. M.tuberculosisMycobacterium tuberculosis
  6. M1 receptorMuscarinic acetylcholine receptor M1
  7. M1 receptorsMuscarinic acetylcholine receptor M1
  8. M2 receptorMuscarinic acetylcholine receptor M2
  9. M2 receptorsMuscarinic acetylcholine receptor M2
  10. M3 receptorMuscarinic acetylcholine receptor M3
  11. M3 receptorsMuscarinic acetylcholine receptor M3
  12. M5050Diprenorphine
  13. MAC, the Mitochondrial Apoptosis-Induced ChannelMitochondrial apoptosis-induced channel
  14. MACH-1Mortality Assessment In Congestive Heart Failure Trial
  15. MADITMulticenter automatic defibrillator implantation trial
  16. MADIT-IIMulticenter Automatic Defibrillator Implantation Trial II
  17. MAGIC – Presented at AHA 2006Myoblast Autologous Grafting In Ischemic Cardiomyopathy
  18. MAIMycobacterium avium intracellulare
  19. MALDIMatrix-assisted laser desorption/ionization
  20. MALDI-TOFMatrix-assisted laser desorption/ionization
  21. MALTMALT lymphoma
  22. MALT-lymphomaMALT lymphoma
  23. MALT-type lymphomaMALT lymphoma
  24. MALTOMAMALT lymphoma
  25. MALTomasMALT lymphoma
  26. MAOMonoamine oxidase
  27. MAO-AMonoamine oxidase
  28. MAO-BMonoamine oxidase
  29. MAOBMonoamine oxidase B
  30. MAOIMonoamine oxidase inhibitor
  31. MAOIsMonoamine oxidase inhibitor
  32. MAO inhibitorMonoamine oxidase inhibitor
  33. MAO inhibitorsMonoamine oxidase inhibitor
  34. MAPMean arterial pressure
  35. MAPKMitogen-activated protein kinase
  36. MAPPET-3Management Strategies And Prognosis Of Pulmonary Embolism-3 Trial
  37. MAP estimatorMaximum a posteriori
  38. MAP kinaseMitogen-activated protein kinase
  39. MAP kinasesMitogen-activated protein kinase
  40. MARSThe Monitored Atherosclerosis Regression Study
  41. MASCOTManagement Of Atrial Fibrillation Suppression In Af-Hf Comorbidity Therapy
  42. MASHMash
  43. MASP-IMASP1 (protein)
  44. MASP-IIMASP2 (protein)
  45. MASS-IISecond Medicine, Angioplasty, Or Surgery Study
  46. MASS SyndromeMASS syndrome
  47. MAST-EThrombolytic Therapy With Streptokinase In Acute Ischemic Stroke
  48. MASTERMicrovolt T Wave Alternans Testing For Risk Stratification Of Post-Myocardial Infarction Patients
  49. MATMultifocal atrial tachycardia
  50. MATCHManagement Of Atherothrombosis With Clopidogrel In High-Risk Patients

View ( | ) (20 | 50 | 100 | 250 | 500)